Vesta Therapeutics, Inc.
Records under this name other than the patents Vesta Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 3 of 3 · Back to Vesta Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,877,497 | Method of Differentiating Mammalian Progenitor Cells into Insulin Producing Pancreatic Islet Cells Grace period ended · Low confidence | Grace period ended | Low confidence | |
| US 7,413,897 | Primitive and Proximal Hepatic Stem Cells Term ended Term ended Mar 14, 2023 · High confidence | Term ended | Term ended Mar 14, 2023 | High confidence |
| US 8,691,523 | Primitive and proximal hepatic stem cells Lapsed on the fee record Ended Apr 8, 2022 · USPTO record | Lapsed on the fee record | Ended Apr 8, 2022 | USPTO record |